Skip to main content
. 2005 May 31;92(12):2140–2147. doi: 10.1038/sj.bjc.6602650

Figure 4.

Figure 4

SELDI profiles of urine samples from patient 9 on a SAX2 chip (A) and patient 12 on an H4 chip (B). Pre- and postdose 1 and 6, and 4 weeks postcessation of Suramin treatment. Arrows identify peaks that are either lost or gained.